FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

The Harvard Drug Group Carton Label: MAJOR Recall

Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0

The Harvard Drug Group LLC · Dublin, OH

Risk level
Class II
Reported by FDA
Jul 1, 2026
Recall ID
D-0609-2026
Check your lot numberHow we source this data

Summary

The Harvard Drug Group recalled Carton Label: MAJOR starting Jun 16, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0609-2026 on Jul 1, 2026. Reason: Subpotent Drug. Status: Ongoing.

Why it was recalled

Subpotent Drug

Product description

Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg, 20 TABLETS (2 x 10), Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, in 46268, NDC 0904-7282-10. Blister Label: Methylergonovine Maleate Tablets, 0.2 mg, USP, One Tablet, Major Pharm/Indianapolis, IN 46268, NDC 0904-7282-10.

Lot numbers, UPCs & expiration codes

Lots: N02327, expires: 09/2026; N02740, expires: 12/2026; N03069, expires: 08/2027.

Where it was sold

U.S. Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0609-2026
Classification
Class II
Status
Ongoing
Recall initiated
Jun 16, 2026
FDA report date
Jul 1, 2026
Quantity
790 Cartons.
Recall type
Voluntary: Firm initiated
Recalling firm
The Harvard Drug Group LLC

Original FDA data

Every field from FDA enforcement report D-0609-2026, exactly as published.

Show all FDA fields
City
Dublin
State
OH
Status
Ongoing
Country
United States
Event ID
99240
Address
7000 Cardinal Pl
Code information
Lots: N02327, expires: 09/2026; N02740, expires: 12/2026; N03069, expires: 08/2027.
Postal code
43017-1091
Report date
Jul 1, 2026
Product type
Drugs
Recall number
D-0609-2026
Classification
Class II
Recalling firm
The Harvard Drug Group LLC
Product quantity
790 Cartons.
Reason for recall
Subpotent Drug
Voluntary / mandated
Voluntary: Firm initiated
Product description
Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg, 20 TABLETS (2 x 10), Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, in 46268, NDC 0904-7282-10. Blister Label: Methylergonovine Maleate Tablets, 0.2 mg, USP, One Tablet, Major Pharm/Indianapolis, IN 46268, NDC 0904-7282-10.
Distribution pattern
U.S. Nationwide.
Recall initiation date
Jun 16, 2026
Initial firm notification
Letter
Center classification date
Jun 22, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0609-2026, published Jul 1, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls